Mersana Therapeutics
MRSN
MRSN
147 hedge funds and large institutions have $370M invested in Mersana Therapeutics in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 56 increasing their positions, 41 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $437M → $370M (-$67M)
23% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 43
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
147
Holding in Top 10
1
Calls
$18.1M
Puts
$2.24M
Top Buyers
| 1 | +$15.9M | |
| 2 | +$9.49M | |
| 3 | +$9.21M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$5.59M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.46M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$5.91M | |
| 3 | -$5.08M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.96M |
| 5 |
ABG
Ally Bridge Group
New York
|
-$4.9M |